Skip to main content
. 2004 Jan 6;90(1):100–105. doi: 10.1038/sj.bjc.6601468

Table 3. Toxicities of EMP/VBL and EMP (NCIC-CTG).

  No of patients with NCIC-CTG grade toxicity
Type of toxicity 1 2 3 4 %
(a) EMP/VBL
 Cardiovasculara 1 5 4 2b 27.9
 Gynecomastia 13 1     32.6
 Diarrhoea 4 1 2   16.3
 Nausea 8 8 3   44.2
 Vomiting 5 3     18.6
 Other gastrointestinac 3 3 1   16.3
 Alopecia 4       9.3
 Neurologicald 6 4 2   27.9
 Bilirubin rise   2 1 1 9.3
 SGOT rise 13 1     32.6
 Platelets 8 1     20.9
 Haemoglobin 18 15 1   76.7
 WBC 4 1     11.6
 
(b) EMP
 Cardiovasculare 3 5 4   26.7
 Gynecomastia 6 7     28.9
 Diarrhoea 6 1 1   17.8
 Nausea 9 11 5   55.6
 Vomiting 9 5 1 1 35.6
 Other gastrointestinalf 4 3 1   17.8
 Alopecia 4 1     11.1
 Neurologicalg 3 7 3   28.9
 Bilirubin rise   5 3 2 22.2
 SGOT rise 9 2     24.4
 Platelets 6 1 1   17.8
 Haemoglobin 23 8 2   73.3
 WBC 2       2.2
a

Cardiovascular toxicity: venous thrombosis 2, oedema, pulmonary embolism, myocardial infarction, atrial fibrillation, insufficient cardiac function.

b

2 deaths (myocardial infarction, stroke).

c

Two other gastrointestinal toxicity: abdominal pain 2, sensitive oesophagus, pyrosis.

d

Neurological toxicity: constipation 4, depression 2, muscle cramping 2, paresthesia.

e

Cardiovascular toxicity: oedema 7, venous thrombosis 2, pulmonary embolism, atrial fibrillation, insufficient cardiac function.

f

Other gastrointestinal toxicity: anorexia 4, abdominal pain 3.

g

Neurological toxicity: constipation 8, depression, muscle cramping, paresthesia.